Replies to post #54 on ISTA Pharmaceuticals Inc. (ISTA)

[surf1944]

2. ISTA Pharmaceuticals Inc. (ISTA): Develops, and markets remedies for diseases and conditions of the eye in the United States. Market cap of $169.95M. Projected 5-year EPS growth at 25.00%. Price at $3.94. Net institutional shares purchased over the current quarter at 10.7M, which is 31.94% of the company's 33.50M share float.

18 High-Growth Smart Money Picks Trading Under $5

http://seekingalpha.com/article/292600-18-high-growth-smart-money-picks-trading-under-5?source=yahoo